| 1 |
Salminen A, Kaarniranta K, Kauppinen A. Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency[J]. Cell Mol Life Sci, 2019, 76 (10): 1901-1918.
|
| 2 |
马骋，阮清伟，俞卓伟. 氧化应激与免疫衰老[J]. 中华老年医学杂志，2017，36(2)：224-228.
|
| 3 |
Shanley DP, Aw D, Manley NR, et al. An evoluti-onary perspective on the mechanisms of immunosen-escence[J]. Trends Immunol, 2009, 30 (7): 374-381.
|
| 4 |
Goidl EA, Innes JB, Weksler ME. Immunological stu-dies of aging. Ⅱ. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice[J]. J Exp Med, 1976, 144 (4): 1037-1048.
|
| 5 |
Roder JC, Duwe AK, Bell DA, et al. Immunological senescence. Ⅰ. The role of suppressor cells[J]. Immunology, 1978, 35 (5): 837-847.
|
| 6 |
Singhal SK, Roder JC, Duwe AK. Suppressor cells in immunosenescence[J]. Fed Proc, 1978, 37 (5): 1245-1252.
|
| 7 |
Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosene-scence[J]. Ann N Y Acad Sci, 2000 (908): 244-254.
|
| 8 |
Ostrand-Rosenberg S, Sinha P, Beury DW, et al. Cr-oss-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression[J]. Semin Cancer Biol, 2012, 22 (4): 275-281.
|
| 9 |
Lindau D, Gielen P, Kroesen M, et al. The immuno-suppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells[J]. Immunology, 2013, 138 (2): 105-115.
|
| 10 |
Salminen A, Kaarniranta K, Kauppinen A. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process[J]. Ageing Res Rev, 2018 (48): 1-10.
|
| 11 |
冯世兴，朱鸣雷，刘晓红. 炎性衰老与常见老年病的关系[J]. 中国临床保健杂志，2018，21(1)：139-142.
|
| 12 |
Kovtonyuk LV, Fritsch K, Feng X, et al. Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment[J]. Front Immunol, 2016 (7): 502.
|
| 13 |
Salminen A, Kaarniranta K, Kauppinen A. Inflam-maging: disturbed interplay between autophagy and inflammasomes[J]. Aging (Albany NY), 2012, 4 (3): 166-175.
|
| 14 |
Franceschi C, Garagnani P, Parini P, et al. Inflam-maging: a new immune-metabolic viewpoint for age-related diseases[J]. Nat Rev Endocrinol, 2018, 14 (10): 576-590.
|
| 15 |
Fulop T, Witkowski JM, Olivieri F, et al. The in-tegration of inflammaging in age-related diseases[J]. Semin Immunol, 2018 (40): 17-35.
|
| 16 |
Munoz-Espin D, Serrano M. Cellular senescence: from physiology to pathology[J]. Nat Rev Mol Cell Biol, 2014, 15 (7): 482-496.
|
| 17 |
Salminen A, Kauppinen A, Kaarniranta K. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence[J]. Biogerontology, 2018, 19 (5): 325-339.
|
| 18 |
Minciullo PL, Catalano A, Mandraffino G, et al. Infl-ammaging and anti-inflammaging: the role of cytokines in extreme longevity[J]. Arch Immunol Ther Exp (Warsz), 2016, 64 (2): 111-126.
|
| 19 |
Straub RH, Cutolo M. Glucocorticoids and chronic inflammation[J]. Rheumatology (Oxford), 2016, 55 (Suppl 2): 6-14.
|
| 20 |
Gaffey AE, Bergeman CS, Clark LA, et al. Aging and the HPA axis: stress and resilience in older adults[J]. Neurosci Biobehav Rev, 2016 (68): 928-945.
|
| 21 |
Wang M, Zhang L, Zhu W, et al. Calorie restriction curbs proinflammation that accompanies arterial aging, preserving a youthful phenotype[J]. J Am Heart Assoc, 2018, 7 (18): e009112.
|
| 22 |
Zhang K, Bai X, Li R, et al. Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma[J]. Int J Mol Med, 2012, 30 (2): 277-282.
|
| 23 |
Fulop T, Larbi A, Dupuis G, et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?[J]. Front Immunol, 2018 (8): 1960.
|
| 24 |
Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age[J]. Proc Natl Acad Sci U S A, 2011, 108 (50): 20012-20017.
|
| 25 |
Mann M, Mehta A, de Boer CG, et al. Heterogeneous responses of hematopoietic stem cells to inflammatory stimuli are altered with age[J]. Cell Rep, 2018, 25 (11): 2992-3005.e5.
|
| 26 |
Schultze JL, Mass E, Schlitzer A. Emerging principles in myelopoiesis at homeostasis and during infection and inflammation[J]. Immunity, 2019, 50 (2): 288-301.
|
| 27 |
赵睿，董晨，周为，等. 人体免疫衰老与肿瘤及感染的关系研究进展[J]. 中华医学杂志，2019，99(16)：1278-1280.
|
| 28 |
Ruan WS, Feng MX, Xu J, et al. Early activation of myeloid-merived suppressor cells participate in sepsis-induced immune suppression via PD-L1/PD-1 axis[J]. Front Immunol, 2020 (11): 1299.
|
| 29 |
Li L, Lu YQ. The regulatory role of high-mobility group protein 1 in sepsis-related immunity[J]. Front Immunol, 2021 (11): 601815.
|
| 30 |
Heithoff DM, Enioutina EY, Bareyan D, et al. Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity[J]. Infect Immun, 2008, 76 (11): 5191-5199.
|
| 31 |
Grizzle WE, Xu X, Zhang S, et al. Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice[J]. Mech Ageing Dev, 2007, 128 (11-12): 672-680.
|
| 32 |
Flores RR, Clauson CL, Cho J, et al. Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-κB-dependent mechanism[J]. Aging Cell, 2017, 16 (3): 480-487.
|
| 33 |
Verschoor CP, Johnstone J, Millar J, et al. Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and history of cancer[J]. J Leukoc Biol, 2013, 93 (4): 633-637.
|
| 34 |
Alves AS, Ishimura ME, Duarte YAO, et al. Param-eters of the immune system and vitamin D levels in old individuals[J]. Front Immunol, 2018 (9): 1122.
|
| 35 |
Roszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms[J]. Mediators Inflamm, 2015 (2015): 816460.
|
| 36 |
Jackaman C, Radley-Crabb HG, Soffe Z, et al. Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice[J]. Aging Cell, 2013, 12 (3): 345-357.
|
| 37 |
Duong L, Radley-Crabb HG, Gardner JK, et al. Mac-rophage depletion in elderly mice improves response to tumor immunotherapy, increases anti-tumor T cell activity and reduces treatment-induced cachexia[J]. Front Genet, 2018 (9): 526.
|
| 38 |
Mahbub S, Deburghgraeve CR, Kovacs EJ. Advanced age impairs macrophage polarization[J]. J Interferon Cytokine Res, 2012, 32 (1): 18-26.
|
| 39 |
Rosenkranz D, Weyer S, Tolosa E, et al. Higher fre-quency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration[J]. J Neuroimmunol, 2007, 188 (1-2): 117-127.
|
| 40 |
Chougnet CA, Tripathi P, Lages CS, et al. A major role for Bim in regulatory T cell homeostasis[J]. J Immunol, 2011, 186 (1): 156-163.
|
| 41 |
Raynor J, Karns R, Almanan M, et al. IL-6 and ICOS antagonize Bim and promote regulatory T cell accrual with age[J]. J Immunol, 2015, 195 (3): 944-952.
|
| 42 |
Garg SK, Delaney C, Toubai T, et al. Aging is associated with increased regulatory T-cell function[J]. Aging Cell, 2014, 13 (3): 441-448.
|
| 43 |
Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters[J]. Nat Med, 2009, 15 (8): 930-939.
|
| 44 |
Kalathookunnel Antony A, Lian Z, Wu H. T cells in adipose tissue in aging[J]. Front Immunol, 2018 (9): 2945.
|
| 45 |
Bapat SP, Myoung Suh J, Fang S, et al. Depletion of fat-resident Treg cells prevents age-associated insulin resistance[J]. Nature, 2015, 528 (7580): 137-141.
|
| 46 |
Agius E, Lacy KE, Vukmanovic-Stejic M, et al. Decreased TNF-α synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging[J]. J Exp Med, 2009, 206 (9): 1929-1940.
|
| 47 |
Burzyn D, Kuswanto W, Kolodin D, et al. A special population of regulatory T cells potentiates muscle repair[J]. Cell, 2013, 155 (6): 1282-1295.
|
| 48 |
Kuswanto W, Burzyn D, Panduro M, et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells[J]. Immunity, 2016, 44 (2): 355-367.
|
| 49 |
Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function[J]. Immunity, 2015, 42 (4): 607-612.
|
| 50 |
Swain SL, Kugler-Umana O, Kuang Y, et al. The properties of the unique age-associated B cell subset reveal a shift in strategy of immune response with age[J]. Cell Immunol, 2017 (321): 52-60.
|
| 51 |
Gardner JK, Jackaman C, Mamotte CDS, et al. The regulatory status adopted by lymph node dendritic cells and T cells during healthy aging is maintained during cancer and may contribute to reduced responses to immunotherapy[J]. Front Med (Lausanne), 2018 (5): 337.
|
| 52 |
Versteven M, Van den Bergh JMJ, Marcq E, et al. Dendritic cells and programmed death-1 blockade: a joint venture to combat cancer[J]. Front Immunol, 2018 (9): 394.
|
| 53 |
Challier J, Bruniquel D, Sewell AK, et al. Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8+ T-cell priming capacity[J]. Immunology, 2013, 138 (4): 402-410.
|
| 54 |
Liu WM, Nahar TE, Jacobi RH, et al. Impaired production of TNF-α by dendritic cells of older adults leads to a lower CD8+ T cell response against influenza[J]. Vaccine, 2012, 30 (9): 1659-1666.
|
| 55 |
Huang H, Dawicki W, Zhang X, et al. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells[J]. J Immunol, 2010, 185 (9): 5003-5010.
|
| 56 |
Bradley BA. Rejection and recipient age[J]. Transpl Immunol, 2002, 10 (2-3): 125-132.
|
| 57 |
Aspinall R, Del Giudice G, Effros RB, et al. Challenges for vaccination in the elderly[J]. Immun Ageing, 2007 (4): 9.
|
| 58 |
Almeida-Oliveira A, Smith-Carvalho M, Porto LC, et al. Age-related changes in natural killer cell receptors from childhood through old age[J]. Hum Immunol, 2011, 72 (4): 319-329.
|
| 59 |
Beli E, Duriancik DM, Clinthorne JF, et al. Natural killer cell development and maturation in aged mice[J]. Mech Ageing Dev, 2014 (135): 33-40.
|
| 60 |
Manser AR, Uhrberg M. Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance[J]. Cancer Immunol Immunother, 2016, 65 (4): 417-426.
|
| 61 |
Poli A, Michel T, Thérésine M, et al. CD56bright natural killer (NK) cells: an important NK cell subset[J]. Immunology, 2009, 126 (4): 458-465.
|
| 62 |
Fu B, Tian Z, Wei H. Subsets of human natural killer cells and their regulatory effects[J]. Immunology, 2014, 141 (4): 483-489.
|
| 63 |
Terabe M, Berzofsky JA. Tissue-specific roles of NKT cells in tumor immunity[J]. Front Immunol, 2018 (9): 1838.
|
| 64 |
Peralbo E, Alonso C, Solana R. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing[J]. Exp Gerontol, 2007, 42 (8): 703-708.
|
| 65 |
Ko HJ, Lee JM, Kim YJ, et al. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine[J]. J Immunol, 2009, 182 (4): 1818-1828.
|
| 66 |
Venken K, Decruy T, Aspeslagh S, et al. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells[J]. J Immunol, 2013, 191 (5): 2174-2183.
|
| 67 |
Trayssac M, Hannun YA, Obeid LM. Role of sphingolipids in senescence: implication in aging and age-related diseases[J]. J Clin Invest, 2018, 128 (7): 2702-2712.
|
| 68 |
Coppé JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor[J]. PLoS Biol, 2008, 6 (12): 2853-2868.
|
| 69 |
da Silva PFL, Ogrodnik M, Kucheryavenko O, et al. The bystander effect contributes to the accumulation of senescent cells in vivo[J]. Aging Cell, 2019, 18 (1): e12848.
|
| 70 |
Pereira BI, Devine OP, Vukmanovic-Stejic M, et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition[J]. Nat Commun, 2019, 10 (1): 2387.
|
| 71 |
Moreau JF, Pradeu T, Grignolio A, et al. The emerging role of ECM crosslinking in T cell mobility as a hallmark of immunosenescence in humans[J]. Ageing Res Rev, 2017 (35): 322-335.
|
| 72 |
Freitas-Rodriguez S, Folgueras AR, López-Otin C. The role of matrix metalloproteinases in aging: tissue remodeling and beyond[J]. Biochim Biophys Acta Mol Cell Res, 2017, 1864 (11 Pt A): 2015-2025.
|
| 73 |
Sangaletti S, Chiodoni C, Tripodo C, et al. Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments[J]. Cancer Immunol Immunother, 2017, 66 (8): 1059-1067.
|
| 74 |
Bueno V, Sant'Anna OA, Lord JM. Ageing and myeloid derived suppressor cells: possible involvement in immunosenescence and age-related disease[J]. Age (Dordr), 2014, 36 (6): 9729.
|